PHARMACEUTICAL FORMULATION OF BEVACIZUMAB

The invention provides a stable aqueous pharmaceutical formulation comprising a therapeutically effective amount of an antibody, optionally, not subjected to prior lyophilization, a buffer maintaining the pH in the range from about 4.0 to about 6.0, and an optional surfactant, methods for making suc...

Full description

Saved in:
Bibliographic Details
Main Authors KAMERZELL, TIMOTHY J, CROMWELL, MARY, GOKARN, YATIN R, LIU, HONG, LI, MEGAN
Format Patent
LanguageEnglish
Polish
Published 30.04.2020
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The invention provides a stable aqueous pharmaceutical formulation comprising a therapeutically effective amount of an antibody, optionally, not subjected to prior lyophilization, a buffer maintaining the pH in the range from about 4.0 to about 6.0, and an optional surfactant, methods for making such a formulation, and methods of using such a formulation.
Bibliography:Application Number: PL20100798236T